Clinical Trial Update: Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas [Phase 1]

View source ↗

Summary

This document reports an early-phase (Phase 1) clinical trial evaluating the combination of enzastaurin and temozolomide in patients with primary gliomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Enzastaurin (enzastaurin)
• Temozolomide (Temozolomide)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: UNKNOWN